Christina Dahl

2.7k total citations
34 papers, 1.6k citations indexed

About

Christina Dahl is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Christina Dahl has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in Christina Dahl's work include Epigenetics and DNA Methylation (10 papers), Melanoma and MAPK Pathways (6 papers) and RNA modifications and cancer (5 papers). Christina Dahl is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Melanoma and MAPK Pathways (6 papers) and RNA modifications and cancer (5 papers). Christina Dahl collaborates with scholars based in Denmark, Norway and United Kingdom. Christina Dahl's co-authors include Per Guldberg, Kirsten Grønbæk, Cecilie Abildgaard, Christina M. Dahmcke, Lone Bredo Pedersen, Carsten Utoft Niemann, Mats Jerkeman, Christian Winther Eskelund, Christian H. Geisler and Arne Kolstad and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Blood.

In The Last Decade

Christina Dahl

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christina Dahl Denmark 21 863 604 359 266 220 34 1.6k
Anat Erdreich‐Epstein United States 27 957 1.1× 311 0.5× 119 0.3× 380 1.4× 515 2.3× 60 1.9k
Bodour Salhia United States 26 914 1.1× 580 1.0× 170 0.5× 483 1.8× 296 1.3× 69 2.0k
Bruno Alicke United States 21 1.8k 2.1× 566 0.9× 233 0.6× 215 0.8× 259 1.2× 32 2.3k
Morgan O’Hayre United States 14 927 1.1× 421 0.7× 100 0.3× 141 0.5× 127 0.6× 18 1.5k
Charles Decraene France 22 645 0.7× 596 1.0× 149 0.4× 571 2.1× 50 0.2× 40 1.4k
Najim Ameziane Netherlands 19 1.3k 1.5× 504 0.8× 216 0.6× 353 1.3× 100 0.5× 47 1.7k
Fréderic Fina France 27 893 1.0× 687 1.1× 186 0.5× 506 1.9× 719 3.3× 87 2.2k
Josée Hébert Canada 33 2.2k 2.5× 550 0.9× 122 0.3× 389 1.5× 257 1.2× 93 3.1k
Damian Yap Canada 18 1.3k 1.5× 548 0.9× 304 0.8× 671 2.5× 85 0.4× 24 1.9k
Duncan Stearns United States 17 1.1k 1.3× 627 1.0× 119 0.3× 372 1.4× 765 3.5× 31 2.1k

Countries citing papers authored by Christina Dahl

Since Specialization
Citations

This map shows the geographic impact of Christina Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Dahl more than expected).

Fields of papers citing papers by Christina Dahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Dahl. The network helps show where Christina Dahl may publish in the future.

Co-authorship network of co-authors of Christina Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Dahl. A scholar is included among the top collaborators of Christina Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Dahl. Christina Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Traynor, Sofie, Christina Dahl, Mette Stæhr, et al.. (2025). Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition. Journal of Experimental & Clinical Cancer Research. 44(1). 21–21. 3 indexed citations
2.
Frías, Alex, Luca Di Leo, Asier Antoranz, et al.. (2023). Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma. Journal for ImmunoTherapy of Cancer. 11(3). e006389–e006389. 5 indexed citations
3.
Jeanmougin, Marine, Eirill Ager-Wick, Hege Marie Vedeld, et al.. (2022). BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients. Clinical Epigenetics. 14(1). 115–115. 11 indexed citations
4.
Dahl, Christina, Per Guldberg, & Cecilie Abildgaard. (2019). Evaluating the Role of RARβ Signaling on Cellular Metabolism in Melanoma Using the Seahorse XF Analyzer. Methods in molecular biology. 2019. 171–180. 4 indexed citations
5.
Lind, Guro E., et al.. (2019). DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies. International Journal of Molecular Sciences. 20(11). 2657–2657. 50 indexed citations
6.
Jerkeman, Mats, Christian Winther Eskelund, Martin Hutchings, et al.. (2018). Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial. The Lancet Haematology. 5(3). e109–e116. 100 indexed citations
7.
Eskelund, Christian Winther, Christina Dahl, Jakob Werner Hansen, et al.. (2017). TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood. 130(17). 1903–1910. 242 indexed citations
8.
Bak, Mads, Susanne E. Boonen, Christina Dahl, et al.. (2016). Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57. BMC Medical Genetics. 17(1). 29–29. 26 indexed citations
9.
Dahmcke, Christina M., et al.. (2016). A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria. European Urology. 70(6). 916–919. 58 indexed citations
10.
Honne, Hilde, Hege Marie Vedeld, Christina Dahl, et al.. (2016). Experimental factors affecting the robustness of DNA methylation analysis. Scientific Reports. 6(1). 33936–33936. 14 indexed citations
11.
Dahl, Christina, Cecilie Abildgaard, Rikke Riber‐Hansen, et al.. (2014). KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma. Journal of Investigative Dermatology. 135(2). 516–524. 34 indexed citations
12.
Dahl, Christina, Claus Christensen, Göran Jönsson, et al.. (2013). Mutual Exclusivity Analysis of Genetic and Epigenetic Drivers in Melanoma Identifies a Link Between p14ARF and RARβ Signaling. Molecular Cancer Research. 11(10). 1166–1178. 21 indexed citations
13.
Dahl, Christina, Kirsten Grønbæk, & Per Guldberg. (2011). Advances in DNA methylation: 5-hydroxymethylcytosine revisited. Clinica Chimica Acta. 412(11-12). 831–836. 81 indexed citations
14.
Serizawa, Reza, Ulrik Ralfkiær, Christina Dahl, et al.. (2010). Custom-Designed MLPA Using Multiple Short Synthetic Probes. Journal of Molecular Diagnostics. 12(4). 402–408. 20 indexed citations
15.
Mellemkjær, Lene, Christina Dahl, Jørgen H. Olsen, et al.. (2008). Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study. British Journal of Cancer. 98(4). 728–733. 33 indexed citations
16.
Dahl, Christina, Karen Grønskov, Lars Allan Larsen, Per Guldberg, & Karen Brøndum‐Nielsen. (2007). A Homogeneous Assay for Analysis of FMR1 Promoter Methylation in Patients with Fragile X Syndrome. Clinical Chemistry. 53(4). 790–793. 27 indexed citations
17.
Dahl, Christina & Per Guldberg. (2007). A ligation assay for multiplex analysis of CpG methylation using bisulfite-treated DNA. Nucleic Acids Research. 35(21). e144–e144. 26 indexed citations
18.
Straten, Per thor, Christina Dahl, David Schrama, et al.. (2005). Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes. Cancer Immunology Immunotherapy. 55(5). 495–502. 16 indexed citations
19.
Dahl, Christina, et al.. (2000). Reduced [3H]IP3 binding but unchanged IP3 receptor levels in the rat hippocampus CA1 region following transient global ischemia and tolerance induction. Neurochemistry International. 36(4-5). 379–388. 18 indexed citations
20.
Møbjerg, Nadja & Christina Dahl. (1996). Studies on the morphology and ultrastructure of the Malpighian tubules of Halobiotus crispae Kristensen, 1982 (Eutardigrada). Zoological Journal of the Linnean Society. 116(1-2). 85–99. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anat Erdreich‐Epstein Breakdown of academic impact, for papers by Bodour Salhia Breakdown of academic impact, for papers by Bruno Alicke Breakdown of academic impact, for papers by Morgan O’Hayre Breakdown of academic impact, for papers by Charles Decraene Breakdown of academic impact, for papers by Najim Ameziane Breakdown of academic impact, for papers by Fréderic Fina Breakdown of academic impact, for papers by Josée Hébert Breakdown of academic impact, for papers by Damian Yap Breakdown of academic impact, for papers by Duncan Stearns
Rankless by CCL
2026